You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: March 30, 2020

DrugPatentWatch Database Preview

Drug Price Trends for LEVETIRACETAM

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Drug Price Trends for LEVETIRACETAM

Average Pharmacy Cost for LEVETIRACETAM

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
LEVETIRACETAM 1,000 MG TABLET 71930-0065-60 0.23440 EACH 2020-03-18
LEVETIRACETAM 750 MG TABLET 71930-0064-15 0.17633 EACH 2020-03-18
LEVETIRACETAM 500 MG TABLET 71930-0063-52 0.12880 EACH 2020-03-18
LEVETIRACETAM 500 MG TABLET 71930-0063-15 0.12880 EACH 2020-03-18
LEVETIRACETAM 250 MG TABLET 71930-0062-15 0.08652 EACH 2020-03-18
LEVETIRACETAM ER 750 MG TABLET 69076-0750-60 0.56096 EACH 2020-03-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for LEVETIRACETAM

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
KEPPRA 100MG/ML ORAL SOLN UCB, Inc. 50474-0001-48 480ML 516.02 1.07504 ML 2019-09-15 - 2024-09-14 Big4
KEPPRA 250MG TAB UCB, Inc. 50474-0594-40 120 698.62 5.82183 EACH 2020-01-01 - 2024-09-14 FSS
KEPPRA 1000MG TAB UCB, Inc. 50474-0597-66 60 640.19 10.66983 EACH 2020-01-01 - 2024-09-14 Big4
KEPPRA 100MG/ML ORAL SOLN UCB, Inc. 50474-0001-48 480ML 649.09 1.35227 ML 2019-09-15 - 2024-09-14 FSS
KEPPRA 500MG TAB UCB, Inc. 50474-0595-40 120 615.47 5.12892 EACH 2019-09-15 - 2024-09-14 Big4
KEPPRA 1000MG TAB UCB, Inc. 50474-0597-66 60 853.87 14.23117 EACH 2020-01-01 - 2024-09-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.